Table 1.

Demographic and clinical data of 30 study participants

Patient no.	Age (years)	Sex	Weight (kg)	Disease	Injected 18F-FDG dose (mCi)	First acquisition PET/CT	Start Time (min)	Time delay (min)
1	81	F	36	Thyroid cancer	4.27	Standard	60	28
2	50	M	78	Cancer screening	6.11	Standard	68	35
3	77	F	58	Breast cancer	5.43	Digital	60	18
4	61	M	62	Lung cancer	5.76	Digital	59	21
5	54	F	55	Liposarcoma	5.30	Standard	62	20
6	72	M	61	Stomach cancer	6.38	Standard	56	13
7	39	F	70	Cervical cancer	6.43	Digital	57	16
8	73	M	54	Stomach cancer	5.08	Digital	62	22
9	57	F	50	Breast cancer	4.96	Digital	55	15
10	44	F	49	Thyroid cancer	5.76	Standard	56	13
11	55	F	61	Breast cancer	6.00	Standard	63	13
12	76	M	65	Colon cancer	6.92	Digital	55	20
13	50	F	53	GIST	5.38	Standard	63	14
14	58	F	42	Breast cancer	5.05	Standard	60	14
15	69	M	61	Lung cancer	5.78	Digital	73	21
16	62	F	56	Lung cancer	6.22	Digital	70	20
17	73	F	43	Breast cancer	5.11	Digital	66	23
18	81	F	47	Cervical cancer	4.70	Digital	65	27
19	65	M	48	Esophageal cancer	4.78	Standard	68	15
20	61	F	66	Cancer screening	5.27	Standard	62	12
21	72	F	36	Cervical cancer	4.32	Digital	63	15
22	39	F	55	Cervical cancer	5.73	Digital	54	14
23	61	F	59	Lung cancer	6.05	Digital	56	17
24	67	M	64	Lung cancer	6.19	Digital	69	14
25	59	F	55	Cervical cancer	5.65	Standard	55	13
26	68	M	54	Lung cancer	6.70	Standard	70	14
27	65	M	65	Lymphoma	5.43	Digital	56	17
28	59	F	81	Breast cancer	7.76	Standard	63	17
29	77	M	63	Colon cancer	5.92	Standard	54	16
30	64	F	56	Tongue cancer	4.76	Standard	64	12

GIST, gastrointestinal stromal tumor